Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

METHYLDOPATE HYDROCHLORIDE

METHYLDOPATE HYDROCHLORIDE

Standard Dose
50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview METHYLDOPATE HYDROCHLORIDE is listed in Drugs@FDA under application 072974 (ANDA).

Marketing status: Discontinued Active ingredient METHYLDOPATE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 50MG/ML Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2000-03-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview METHYLDOPATE HYDROCHLORIDE is listed in Drugs@FDA under application 072974 (ANDA). Marketing status: Discontinued Active ingredient METHYLDOPATE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 50MG/ML Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2000-03-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.